1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Life...

Let's Pass it on...

Know More

Organs wasted are lives lost....

Become an Organ Donor-Saves Lives...

Know More

Don't Take your organs to Heaven...

Know More

Organ Donation

If you save one life,It is as though you save the world

07Nov/11

Top Q3 2011 Healthcare Stocks of This Popular Investment Fund – Wall St. Cheat Sheet

November 7, 2011Transplant Rejectionadmin

Top Q3 2011 Healthcare Stocks of This Popular Investment FundWall St. Cheat SheetThe Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and ps…

07Nov/11

Ethan Zohn: Survivor star completes NYC marathon despite cancer battle – Daily Mail

November 7, 2011Other Transplantationadmin

E! OnlineEthan Zohn: Survivor star completes NYC marathon despite cancer battleDaily MailThe reality star, who was diagnosed with a rare form of Hodgkin's lymphoma in 2009 and underwent two unsuccessful rounds of chemotherapy, but was declared in r…

07Nov/11

Hundreds of Soldiers & Vets Dying From Antipsychotic–Seroquel – MarketWatch (press release)

November 7, 2011Brain Death Declarationadmin

Hundreds of Soldiers & Vets Dying From Antipsychotic–SeroquelMarketWatch (press release)However, the deaths of the 'Charleston Four' were probable sudden cardiac deaths (SCD), a sudden, pulseless condition leading to brain death in 4-5 min…

07Nov/11

FDA panel gives nod to Merck's Vytorin – Cardiovascular Business

November 7, 2011Organ Failureadmin

FDA panel gives nod to Merck's VytorinCardiovascular Business2 to recommend Merck's Vytorin (combination ezetimibe/simvastatin) for use in patients with pre-dialysis chronic kidney disease. However, when it came to whether or not the approval s…

07Nov/11

Current Challenges in the Management of Patients with Relapsed/Refractory … – Cancer Network

November 7, 2011Other Transplantationadmin

Current Challenges in the Management of Patients with Relapsed/Refractory …Cancer NetworkPatients who relapse within 1 year of a stem-cell transplant (SCT) may require multidrug rescue therapy, followed by allogeneic SCT with reduced-intensity condit…

07Nov/11

Diabetes drug knocks down inflammation – Futurity: Research News

November 7, 2011Immunosuppressive Drugsadmin

Diabetes drug knocks down inflammationFuturity: Research News"Apart from corticosteroids, which are known anti-inflammatory drugs, and insulin, no other drug demonstrates such a powerful and rapid anti-inflammatory effect," says senior author…

07Nov/11

Chimerix Honored With "2011 Southeast BIO Deal of the Year: Venture Capital … – MarketWatch (press release)

November 7, 2011Other Transplantationadmin

Chimerix Honored With "2011 Southeast BIO Deal of the Year: Venture Capital …MarketWatch (press release)Clinical studies of CMX001 include an ongoing Phase 2 study of the prevention/control of CMV in adult hematopoietic stem cell transplant pati…

07Nov/11

Kidney disease education class – Lodi News-Sentinel

November 7, 2011Organ Failureadmin

Kidney disease education classLodi News-SentinelA chronic kidney disease class will be held from 1 to 3 pm Nov. 16 at 777 S. Ham Lane, Suite L, Lodi. Participants can ask questions about their kidney health, find out more about chronic kidney disease, …

07Nov/11

Liver donation can cause complications – Press TV

November 7, 2011Transplantationadmin

Press TVLiver donation can cause complicationsPress TVLiver transplantation has saved many lives among patients suffering from failure and severe dysfunction of the vital organ. Doctors already use liver obtained from cadaver or living donors but the s…

07Nov/11

Recent Multiple Sclerosis Market Events Have Resulted in Treatment Algorithm … – MarketWatch (press release)

November 7, 2011Monoclonal Anti-IL-2Rα Receptor Antibodiesadmin

Recent Multiple Sclerosis Market Events Have Resulted in Treatment Algorithm …MarketWatch (press release)Patient profiles for the seven DMAs in late clinical development (alemtuzumab, BG-12, teriflunomide, laquinimod, PEG-Avonex, daclizumab, ocrelizu…

Posts navigation

  • « Previous
  • 1
  • …
  • 18,376
  • 18,377
  • 18,378
  • 18,379
  • 18,380
  • …
  • 18,562
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos